George L. Sing, Director at REGENERON PHARMACEUTICALS, INC. (REGN), sold 50,260 shares at $603.53 ($30.5M) on 2020-08-25, disclosed to the SEC on 2020-08-27.
Open-market sale of $30.5M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $600.36 | 1,400 | $841K | 2.8% |
| 2 | $601.75 | 300 | $181K | 0.6% |
| 3 | $602.68 | 400 | $241K | 0.8% |
| 4 | $602.68 | 400 | $241K | 0.8% |
| 5 | $603.53 | 3,000 | $1.8M | 5.9% |
| 6 | $604.43 | 3,705 |
| $2.2M |
| 7.3% |
| 7 | $604.43 | 3,705 | $2.2M | 7.3% |
| 8 | $605.53 | 4,700 | $2.8M | 9.3% |
| 9 | $606.43 | 5,168 | $3.1M | 10.3% |
| 10 | $606.43 | 5,168 | $3.1M | 10.3% |
| 11 | $607.46 | 2,384 | $1.4M | 4.7% |
| 12 | $607.46 | 2,384 | $1.4M | 4.7% |
| 13 | $608.06 | 300 | $182K | 0.6% |
| 14 | $608.06 | 300 | $182K | 0.6% |
| 15 | $609.67 | 760 | $463K | 1.5% |
| 16 | $609.67 | 760 | $463K | 1.5% |
| 17 | $610.42 | 3,793 | $2.3M | 7.6% |
| 18 | $610.42 | 3,793 | $2.3M | 7.6% |
| 19 | $611.60 | 3,840 | $2.3M | 7.7% |
| 20 | $612.00 | 1,000 | $612K | 2.0% |
| 21 | $612.43 | 1,900 | $1.2M | 3.8% |
| 22 | $613.39 | 800 | $491K | 1.6% |
| 23 | $614.15 | 300 | $184K | 0.6% |
| Total | $607.33 avg | 50,260 | $30.5M | 100% |
| Filing → |
| REGN | SELL | 2024-02-12 | $950K | — | Filing → |
| REGN | SELL | 2022-03-01 | $2.5M | — | Filing → |
| REGN | SELL | 2021-11-23 | $2.0M | — | Filing → |